Maria do Carmo Fontourac Pereira

In vitro activity of aztreonam-avibactam against carbapenem-resistant Pseudomonas aeruginosa from Southern Brazil

Abstract Carbapenem-resistant Pseudomonas aeruginosa (CR-PA) has limited therapeutic options, particularly when metallo-β-lactamases are present. We evaluated aztreonam-avibactam (AZA) against 48 clinical P. aeruginosa isolates, including 44 CR-PA with 18 difficult-to-treat resis...